Abstract
Antimicrobial peptides (AMPs) are membrane-targeting short sequence peptides that have potential for the development of new antibiotics. AMPs are generally cationic, and target negatively charged bacterial membranes, resulting in their disruption. The multiple peptide resistance factor (MprF) protein reduces AMP binding to bacterial membranes via the conversion of anionic phosphatidylglycerol (PG) lipids into either zwitterionic Alanyl-phosphatidylglycerol (Ala-PG) or cationic Lysyl-phosphatidylglycerol (Lys-PG) lipids, reducing the negative surface charge present on the membrane.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
